Business Context and Reporting Period
This Form 8-K is a current report filed by Neuralstem, Inc. (not Palisade Bio, Inc.) on March 2, 2015, regarding an event that occurred on March 1, 2015. The filing addresses a compensatory arrangement change for the Company's Chief Executive Officer.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on executive compensation adjustments.
Material Changes
Effective March 1, 2015, the Company's Compensation Committee approved an increase in the annual base salary of I. Richard Garr, Chief Executive Officer. The salary was raised from $407,000 to $440,000. No other provisions of Mr. Garr's employment agreement were changed.
Guidance, Outlook, and Risks
The filing contains no guidance, outlook, management commentary on business performance, risks, contingencies, or unusual items. The sole purpose of the report is to disclose the executive salary adjustment.
Investor Verification Points
- Verify the exact effective date of the salary increase (March 1, 2015).
- Confirm the new annual base salary amount ($440,000) versus the prior amount ($407,000).
- Review the attached Exhibit 10.01 (Form of Employment Agreement Amendment) for any non-monetary terms not explicitly detailed in the summary.
- Note that the registrant is Neuralstem, Inc., not Palisade Bio, Inc.